Incannex Healthcare (IXHL) Net Income towards Common Stockholders (2022 - 2026)

Incannex Healthcare has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$3.9 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
• Net Income towards Common Stockholders advanced to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$726000.0 in Q3 2023 and troughed at -$31.6 million in Q2 2025.
• A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders slumped 646.56% in 2024, then jumped 34.21% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at -$2.9 million in 2022, then slumped by 79.61% to -$5.2 million in 2023, then decreased by 12.46% to -$5.9 million in 2024, then dropped by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.